ADAR and pancreatic neoplasm: Analysis of a CRISPR-Cas9 screen18 identified an ADAR1-dependent pancreatic cancer cell line, PATU-8902, which also expressed high levels of interferon-inducible proteins (Fig. 1c, d and Supplementary Fig. 1b).